1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Agile Therapeutics Inc (AGRX)

  7. Agile Therapeutics Inc (AGRX) News

AGRX

Agile Therapeutics Inc
0.214
-0.016 (-6.96%)
Upgrade to Real-Time
Stock Name Stock Symbol Market Stock Type
Agile Therapeutics Inc AGRX NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
Upgrade Icon
-0.016 -6.96% 0.214 08:10:01
Open Price Low Price High Price Close Price Previous Close
0.22 0.2142 0.234 0.224 0.23
more quote information »

Recent News

Date Time Source Heading
31/3/202307:36EDGARCurrent Report Filing (8-k)
23/3/202321:06EDGARAnnual Report (10-k)
23/3/202307:16EDGARCurrent Report Filing (8-k)
23/3/202307:05GLOBEAgile Therapeutics Reports Fourth Quarter & Full Year 2022..
22/3/202300:05GLOBEAgile Therapeutics to Report Fourth Quarter and Full Year..
15/3/202307:29EDGARCurrent Report Filing (8-k)
28/2/202300:31GLOBEAgile Therapeutics Granted 180-Day Extension by Nasdaq to..
16/2/202300:00PRNUSCorium Pharma Solutions Names Ernie De Paolantonio as Chief..
14/2/202308:34EDGARAmended Statement of Ownership (sc 13g/a)
10/2/202300:00PRNUSCorium Pharma Solutions Names Two Industry Veterans to its..
02/2/202300:01GLOBEAgile Therapeutics Provides Clinical Update on Twirla and..
27/1/202309:12EDGARCurrent Report Filing (8-k)
27/1/202308:30GLOBEAgile Therapeutics Announces Distribution of Series C..
10/1/202308:31EDGARCurrent Report Filing (8-k)
09/1/202323:00GLOBEAgile Therapeutics Provides Updates on 2022 Twirla..
02/12/202200:30GLOBEAgile Therapeutics To Present At The Upcoming RHK Capital..
15/11/202208:56EDGARStatement of Changes in Beneficial Ownership (4)
15/11/202208:55EDGARStatement of Changes in Beneficial Ownership (4)
15/11/202208:55EDGARStatement of Changes in Beneficial Ownership (4)
15/11/202208:52EDGARStatement of Changes in Beneficial Ownership (4)
15/11/202208:50EDGARStatement of Changes in Beneficial Ownership (4)
15/11/202208:50EDGARStatement of Changes in Beneficial Ownership (4)
10/11/202218:45TRMNAgile Therapeutics (AGRX) Gets a Buy from Maxim Group
10/11/202209:06EDGARInitial Statement of Beneficial Ownership (3)
08/11/202208:21EDGARQuarterly Report (10-q)
08/11/202208:05GLOBEAgile Therapeutics Reports Third Quarter 2022 Financial..
26/10/202223:30GLOBEAgile Therapeutics to Report Third Quarter 2022 Financial..
08/10/202207:32TRMNAgile Therapeutics appoints Amy Welsh to chief commercial..
08/10/202207:31EDGARCurrent Report Filing (8-k)
08/10/202207:25GLOBEAgile Therapeutics Announces Reorganization of Leadership..
28/9/202203:15TRMNMaxim Group Keeps Their Buy Rating on Agile Therapeutics..
06/9/202222:30GLOBEAgile Therapeutics to Present at the H.C. Wainwright 24th..
29/8/202222:31EDGARStatement of Changes in Beneficial Ownership (4)
25/8/202206:31EDGARCurrent Report Filing (8-k)
20/8/202206:31EDGARCurrent Report Filing (8-k)
14/8/202200:15TRMNMaxim Group Reaffirms Their Buy Rating on Agile Therapeutics..
12/8/202206:22EDGARQuarterly Report (10-q)
12/8/202206:11EDGARCurrent Report Filing (8-k)
12/8/202206:05GLOBEAgile Therapeutics Reports Second Quarter 2022 Financial..
28/7/202222:05GLOBEAgile Therapeutics to Report Second Quarter 2022 Financial..
13/7/202207:01EDGARStatement of Ownership (sc 13g)
12/7/202222:05GLOBEAgile Therapeutics Updates Second Quarter 2022 Guidance
11/7/202221:55TRMNAgile Therapeutics (AGRX) Receives a Buy from H.C...
09/7/202207:17EDGARCurrent Report Filing (8-k)
08/7/202222:05GLOBEAgile Therapeutics to Participate in Maxim Group’s Upcoming..
07/7/202207:16GLOBEAgile Therapeutics Announces Closing of $24 Million Upsized..
01/7/202223:20GLOBEAgile Therapeutics Announces Pricing of $24 Million Upsized..
01/7/202223:05EDGARRegistration of Additional Securities (up to 20%) (s-1mef)
11/6/202206:49EDGARStatement of Changes in Beneficial Ownership (4)
11/6/202206:49EDGARStatement of Changes in Beneficial Ownership (4)
Your Recent History
NASDAQ
AGRX
Agile Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230401 02:10:26